April 2015 Monthly Test Updates

Published on 04/03/15

New Test Launches and Updates

The following new tests are now available:

  • SCDH1 Diffuse Gastric Cancer Syndrome: CDH1 Gene Sequencing
  • DCO6P Bethlem Myopathy/Ullrich Congenital Muscular Dystrophy: COL6A1-3 Gene Deletion/Duplication Panel 

The following test updates are now live:

  • MCO6P Bethlem Myopathy/Ullrich Congenital Muscular Dystrophy: Sequencing Panel – removed deletion/duplication analysis from the sequencing panel
  • DCIL1 Ciliopathies: Deletion/Duplication Panel – changed gene list based on new array design

Test Requisitions - Things to Remember

Not completing a test requisition form entirely can sometimes lead to unnecessary delays in testing. Below are the most commonly missed items:

  • ICD9 codes
  • Policy holder name and date of birth
  • If any authorizations are obtained for the patient, please include a copy of the authorizations with the requisition.
  • Medicare patients must have a signed Advance Beneficiary Notice of Non-coverage (ABN) included with the requisition, except for following BRCA-related test codes: MM070, MM071, MM072, and MM208. Please note, EGL does not pre-verify benefits for patients with Medicare.
  • Signature in the “Authorization to Assign Benefits” section
  • Front and back copy of the patient’s insurance card
  • Billing pages - regardless of the person or entity to be billed, please complete this information.

Prior Authorization Reminder
When it is determined that a prior authorization is needed for testing, the sample will be placed on a billing hold. EGL will notify the client as to what is required and help with any necessary paperwork.

New and Updated Gene Panels

Industry-leading number of gene panels

EGL Next Generation Sequencing Panels include comprehensive, evidence-based gene lists, improved turnaround times, and reduced pricing.